Consensus recommendations for the use of automated insulin delivery technologies in clinical practice

M Phillip, R Nimri, RM Bergenstal… - Endocrine …, 2023 - academic.oup.com
The significant and growing global prevalence of diabetes continues to challenge people
with diabetes (PwD), healthcare providers, and payers. While maintaining near-normal …

Automated insulin delivery: benefits, challenges, and recommendations. A Consensus Report of the Joint Diabetes Technology Working Group of the European …

JL Sherr, L Heinemann, GA Fleming… - Diabetes …, 2022 - Am Diabetes Assoc
A technological solution for the management of diabetes in people who require intensive
insulin therapy has been sought for decades. The last 10 years have seen substantial …

Fully automated closed-loop insulin delivery in adults with type 2 diabetes: an open-label, single-center, randomized crossover trial

AB Daly, CK Boughton, M Nwokolo, S Hartnell… - Nature medicine, 2023 - nature.com
In adults with type 2 diabetes, the benefits of fully closed-loop insulin delivery, which does
not require meal bolusing, are unclear. In an open-label, single-center, randomized …

[HTML][HTML] Medical devices, smart drug delivery, wearables and technology for the treatment of Diabetes Mellitus

DA Domingo-Lopez, G Lattanzi, LHJ Schreiber… - Advanced drug delivery …, 2022 - Elsevier
Diabetes mellitus refers to a group of metabolic disorders which affect how the body uses
glucose impacting approximately 9% of the population worldwide. This review covers the …

Safety and efficacy of the Omnipod 5 automated insulin delivery system in adults with type 2 diabetes: from injections to hybrid closed-loop therapy

GM Davis, AL Peters, BW Bode, AL Carlson… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE Automated insulin delivery (AID) has rarely been studied in adults with type 2
diabetes. We tested the feasibility of using AID for type 2 diabetes with the Omnipod 5 …

Use of continuous glucose monitoring in the assessment and management of patients with diabetes and chronic kidney disease

J Ling, JKC Ng, JCN Chan, E Chow - Frontiers in Endocrinology, 2022 - frontiersin.org
In developed countries, diabetes is the leading cause of chronic kidney disease (CKD) and
accounts for 50% of incidence of end stage kidney disease. Despite declining prevalence of …

Fully closed-loop glucose control compared with insulin pump therapy with continuous glucose monitoring in adults with type 1 diabetes and suboptimal glycemic …

CK Boughton, S Hartnell, R Lakshman… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE We evaluated the safety and efficacy of fully closed-loop with ultrarapid insulin
lispro in adults with type 1 diabetes and suboptimal glycemic control compared with insulin …

Use of insulin pumps and closed‐loop systems among people living with diabetes: A narrative review of clinical and cost‐effectiveness to enable access to technology …

J Jendle, Y Reznik - Diabetes, Obesity and Metabolism, 2023 - Wiley Online Library
The use of continuous subcutaneous insulin infusion (CSII) via insulin pumps is today
considered standard of care for type 1 diabetes (T1D). Closed‐loop systems combining …

Closed-loop artificial pancreas therapy for type 1 diabetes

K Zhou, D Isaacs - Current Cardiology Reports, 2022 - Springer
Abstract Purpose of Review Closed-loop insulin pump systems (artificial pancreas)
represent the cutting edge of insulin delivery technology. There are only a few systems …

The automated pancreas: a review of technologies and clinical practice

T Biester, M Tauschmann, A Chobot… - Diabetes, Obesity …, 2022 - Wiley Online Library
Insulin pumps and glucose sensors are effective in improving diabetes therapy and reducing
acute complications. The combination of both devices using an algorithm‐driven …